MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 237 filers reported holding MIRATI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $613,100 | +17.0% | 10,958 | -20.4% | 0.00% | – |
Q2 2023 | $524,224 | -54.8% | 13,770 | -56.0% | 0.00% | -100.0% |
Q1 2023 | $1,160,191 | +682.1% | 31,272 | +769.6% | 0.00% | – |
Q4 2022 | $148,335 | -52.6% | 3,596 | -19.2% | 0.00% | – |
Q3 2022 | $313,000 | +513.7% | 4,451 | +424.3% | 0.00% | – |
Q2 2022 | $51,000 | -99.4% | 849 | -98.8% | 0.00% | -100.0% |
Q4 2021 | $8,588,000 | -36.0% | 72,330 | -4.6% | 0.01% | -44.4% |
Q3 2021 | $13,420,000 | -22.3% | 75,855 | -29.0% | 0.01% | -25.0% |
Q2 2021 | $17,267,000 | – | 106,896 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |